Cancer
Researchers identify the most accurate risk prediction models for selecting whom to screen
Below please find summaries of new articles that will be published in the next issue of Annals of Internal Medicine....
Study hints at new target to improve immune therapy in triple-negative breast cancer
Credit: University of Colorado Cancer Center Therapies that recruit the immune system to attack tumors are revolutionizing cancer care. Among...
Deadly cancers show early, detectable differences from benign tumors
DURHAM, N.C. - Do metastatic cancer tumors "break bad" or are they "born bad"? This question is an essential mystery...
Chemotherapy-induced peripheral neuropathy in long-term survivors of childhood cancer
Bottom Line: A new study assesses chemotherapy-induced peripheral neuropathy in 121 long-term survivors of childhood cancer to detail clinical, functional,...
UTA researcher patents ‘roach motel’ for cancer
Credit: UTA The University of Texas at Arlington has successfully patented in Europe an implantable medical device that attracts and...
Study reveals that many oncologists recommend medical marijuana clinically despite not feeling sufficiently knowledgeable to do so
While a wide majority of oncologists do not feel informed enough about medical marijuana's utility to make clinical recommendations, most...
New cancer immunotherapy drugs rapidly reach patients after approval
New Haven, Conn.-- The majority of patients eligible for cancer immunotherapy drugs known as checkpoint inhibitors received treatment within a...
New subtypes of lung cancer can lead to personalized therapies with better outcome
Credit: C. Creighton/Baylor College of Medicine; Oncogene Personalized therapies can potentially improve the outcomes of patients with lung cancer, but...
Cervical cancer screening could be less frequent, start later
Boston, MA – Women may only need cervical cancer screening every 5-10 years–instead of every three years, as currently recommended–and...
Depleting CAR T cells after tumor treatment reverses B cell deficiency in mice
Genetically engineered T cells, or CAR T cells, represent a promising approach to treat multiple types of cancer. These therapies...
OU researchers develop novel, non-invasive cancer therapy
A staggering 1.7 million persons in the United States will be diagnosed with cancer in 2016, with 600,000 cases ending...
A new strategy for choosing cancer drugs
Choosing the best treatment for a cancer patient is often an inexact science. Drugs that work well for some patients...
Stopping breast cancer metastasis in its tracks
A new Tel Aviv University study finds that combining genetic therapy with chemotherapy delivered to a primary tumor site is...
IL-34: New, possible target to tackle drug-resistant cancer cells
A team of researchers has discovered that chemoresistant lung cancer cells suppress immune functions and strengthen resistance to chemotherapy by...
Scientists find lethal vulnerability in treatment-resistant lung cancer
Researchers working in four labs at UT Southwestern Medical Center have found a chink in a so-called “undruggable” lung cancer’s...
How brain tumors spread, become resistant to therapy
Research teams from Karolinska Institutet and Uppsala University have jointly discovered that the usually protective enzyme FBW7 is commonly mutated...
Consumption of a bioactive compound from Neem plant could significantly suppress development of prostate cancer
Oral administration of nimbolide, over 12 weeks shows reduction of prostate tumor size by up to 70 per cent and...
Nanosensors could help determine tumors’ ability to remodel tissue
MIT researchers have designed nanosensors that can profile tumors and may yield insight into how they will respond to certain...
Teen girls with a family history of breast cancer do not experience increased depression or anxiety
More and more girls are expected to have to confront breast cancer fears as modern genomics technology makes it easier...
Skin cancer: Drug combination could improve immunotherapy
The results of studies involving researchers from the MedUni Vienna and Vienna General Hospital Comprehensive Cancer Center (CCC) show that...
